Career & Filing History
Every role Andrew J. Schwab has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Andrew J. Schwab holds the role of Director at Camp4 Therapeutics Corp (CAMP). Schwab's filing history also covers Skye Bioscience, Inc. (SKYE). Schwab has reported 7 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Andrew J. Schwab has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Camp4 Therapeutics Corp (CAMP)4 filingsSkye Bioscience, Inc. (SKYE)1 filingUpdated Aug 30, 2026
Andrew J. Schwab is Director of Camp4 Therapeutics Corp (CAMP). 11 SEC Form 4 filings on record going back to 2024, most recently on 26 August 2026. Most recent open-market trade: sold $45 of CAMP on 26 August 2026. Lifetime open-market purchases: $10.00M. Lifetime open-market sales: $1.82M.
Every recent SEC Form 4 transaction Andrew J. Schwab has reported, most recent first.
InsiderAlpha's records for Andrew J. Schwab go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. The typical open-market purchase is $10.00M (1 buy totaling $10.00M). The largest single buy on record is $10.00M of CAMP in 2024. Sales side: 17 recorded sales totaling $1.82M, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Andrew J. Schwab files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Andrew J. Schwab is a corporate insider, tracked as Director of Camp4 Therapeutics Corp (CAMP). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
5 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchase ($10.00M) and 17 open-market sales ($1.82M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$CAMP Camp4 Therapeutics Corp114.7K shares @ $4.54$521K